Stent-Makers Target the Carotid

The coronary stent market seems to be getting more crowded every day; EndoTex and others are looking to make stents for the trickier-to-handle carotid artery.

As the coronary stent market gets more crowded, stent-makers are looking for new places in the body, anywhere other than the heart, where the small tubes might prove beneficial. Physicians experienced with the devices are on the lookout too. The hot spot of the moment is the carotid artery, which leads to the brain and is, like coronary and other arteries, subject to arteriosclerosis. Clogging in a carotid artery can lead to a stroke in much the same way that an occlusion in the coronary artery can cause a heart attack. Now stent-makers and clinicians alike are wondering whether stents could help keep the carotid artery clear, and so lower the risk of stroke. The currently preferred way to diminish this risk of stroke entails surgical removal of fatty deposits in the coronary. More than 150,000 such procedures, known as endarterectomies, are performed each year in the US, generally on people who have had a stroke or symptoms of stroke. Endarterectomies are effective but expensive and hard on the patient.

Carotid artery stenting may be an alternative to artery-clearing surgery, but the topic is stirring controversy, because many experts believe it is unsafe. Major surgery and general anesthesia are necessary...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By 

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.

Handheld Diagnostics: A Resurging Category That is Here to Stay

 

Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.

Execs On The Move: 12-23 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.